{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T08:40:16Z","timestamp":1770540016392,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s00405-022-07710-2","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T03:29:58Z","timestamp":1666236598000},"page":"963-971","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparison of different treatments for HPV+\u2009oropharyngeal carcinoma: a network meta-analysis"],"prefix":"10.1007","volume":"280","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9639-4486","authenticated-orcid":false,"given":"Fausto","family":"Petrelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Nardone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Trevisan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Carioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Falasca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agostina","family":"De Stefani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Capriotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Gurizzan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Lorini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Berruti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Luciani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Bossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,20]]},"reference":[{"issue":"8","key":"7710_CR1","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S1470-2045(10)70017-6","volume":"11","author":"S Marur","year":"2010","unstructured":"Marur S, D\u2019Souza G, Westra WH, Forastiere AA (2010) HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 11(8):781\u2013789. https:\/\/doi.org\/10.1016\/S1470-2045(10)70017-6","journal-title":"Lancet Oncol"},{"issue":"12","key":"7710_CR2","doi-asserted-by":"publisher","first-page":"djv344","DOI":"10.1093\/jnci\/djv344","volume":"107","author":"EE Vokes","year":"2015","unstructured":"Vokes EE, Agrawal N, Seiwert TY (2015) HPV-associated head and neck cancer. J Natl Cancer Inst 107(12):djv344. https:\/\/doi.org\/10.1093\/jnci\/djv344","journal-title":"J Natl Cancer Inst"},{"issue":"27","key":"7710_CR3","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1200\/JCO.2013.53.5633","volume":"32","author":"KK Ang","year":"2014","unstructured":"Ang KK, Zhang Q, Rosenthal DI et al (2014) Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522. J Clin Oncol 32(27):2940\u20132950. https:\/\/doi.org\/10.1200\/JCO.2013.53.5633","journal-title":"J Clin Oncol"},{"issue":"34","key":"7710_CR4","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1200\/JCO.2014.55.3925","volume":"32","author":"PF Nguyen-Tan","year":"2014","unstructured":"Nguyen-Tan PF, Zhang Q, Ang KK et al (2014) Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the radiation therapy oncology group 0129 trial: long-term report of efficacy and toxicity. J Clin Oncol 32(34):3858\u20133867. https:\/\/doi.org\/10.1200\/JCO.2014.55.3925","journal-title":"J Clin Oncol"},{"issue":"4","key":"7710_CR5","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S1470-2045(20)30737-3","volume":"22","author":"NY Lee","year":"2021","unstructured":"Lee NY, Ferris RL, Psyrri A et al (2021) Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial. Lancet Oncol 22(4):450\u2013462. https:\/\/doi.org\/10.1016\/S1470-2045(20)30737-3","journal-title":"Lancet Oncol"},{"issue":"1","key":"7710_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.radonc.2015.09.024","volume":"117","author":"B Zackrisson","year":"2015","unstructured":"Zackrisson B, Kjell\u00e9n E, S\u00f6derstr\u00f6m K et al (2015) Mature results from a Swedish comparison study of conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma\u2014the ARTSCAN trial. Radiother Oncol 117(1):99\u2013105. https:\/\/doi.org\/10.1016\/j.radonc.2015.09.024","journal-title":"Radiother Oncol"},{"issue":"12","key":"7710_CR7","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1200\/JCO.2015.62.5970","volume":"34","author":"DI Rosenthal","year":"2016","unstructured":"Rosenthal DI, Harari PM, Giralt J et al (2016) Association of human papillomavirus and p16 status with outcomes in the IMCL-9815 phase III registration trial for patients with locoregionally advanced oropharyngeal squamous cell carcinoma of the head and neck treated with radiotherapy with or without C. J Clin Oncol 34(12):1300\u20131308. https:\/\/doi.org\/10.1200\/JCO.2015.62.5970","journal-title":"J Clin Oncol"},{"key":"7710_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32752-1","author":"H Mehanna","year":"2019","unstructured":"Mehanna H, Robinson M, Hartley A et al (2019) Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(18)32752-1","journal-title":"Lancet"},{"key":"7710_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.radonc.2020.01.016","volume":"144","author":"R Fietkau","year":"2020","unstructured":"Fietkau R, Hecht M, Hofner B et al (2020) Randomized phase-III-trial of concurrent chemoradiation for locally advanced head and neck cancer comparing dose reduced radiotherapy with paclitaxel\/cisplatin to standard radiotherapy with fluorouracil\/cisplatin: the PacCis-trial. Radiother Oncol 144:209\u2013217. https:\/\/doi.org\/10.1016\/j.radonc.2020.01.016","journal-title":"Radiother Oncol"},{"issue":"3","key":"7710_CR10","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ijrobp.2016.10.011","volume":"97","author":"M Buglione","year":"2017","unstructured":"Buglione M, Maddalo M, Corv\u00f2 R et al (2017) Subgroup analysis according to human papillomavirus status and tumor site of a randomized phase II trial comparing cetuximab and cisplatin combined with radiation therapy for locally advanced head and neck cancer. Int J Radiat Oncol Biol Phys 97(3):462\u2013472. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.10.011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"7710_CR11","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1200\/JCO.20.03128","volume":"39","author":"SS Yom","year":"2021","unstructured":"Yom SS, Torres-Saavedra P, Caudell JJ et al (2021) Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG Oncology HN002). J Clin Oncol 39(9):956\u2013965. https:\/\/doi.org\/10.1200\/JCO.20.03128","journal-title":"J Clin Oncol"},{"issue":"4","key":"7710_CR12","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.ijrobp.2021.04.015","volume":"111","author":"D Rischin","year":"2021","unstructured":"Rischin D, King M, Kenny L et al (2021) Randomized trial of radiation therapy with weekly cisplatin or cetuximab in low-risk HPV-associated oropharyngeal cancer (TROG 12.01)\u2014a trans-tasman radiation oncology group study. Int J Radiat Oncol Biol Phys 111(4):876\u2013886. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.04.015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10226","key":"7710_CR13","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/S0140-6736(18)32779-X","volume":"395","author":"ML Gillison","year":"2019","unstructured":"Gillison ML, Trotti AM, Harris J et al (2019) Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet 395(10226):784. https:\/\/doi.org\/10.1016\/S0140-6736(18)32779-X","journal-title":"Lancet"},{"key":"7710_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2020.104608","volume":"103","author":"RR Patel","year":"2020","unstructured":"Patel RR, Ludmir EB, Augustyn A et al (2020) De-intensification of therapy in human papillomavirus associated oropharyngeal cancer: a systematic review of prospective trials. Oral Oncol 103:104608. https:\/\/doi.org\/10.1016\/j.oraloncology.2020.104608","journal-title":"Oral Oncol"},{"issue":"18","key":"7710_CR15","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1200\/JCO.21.01293","volume":"40","author":"N Kiyota","year":"2022","unstructured":"Kiyota N, Tahara M, Mizusawa J et al (2022) Weekly cisplatin plus radiation for postoperative head and neck cancer (JCOG1008): a multicenter, noninferiority, phase II\/III randomized controlled trial. J Clin Oncol 40(18):1980\u20131990. https:\/\/doi.org\/10.1200\/JCO.21.01293","journal-title":"J Clin Oncol"},{"issue":"3","key":"7710_CR16","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1001\/jamaoncol.2021.6416","volume":"8","author":"CJ Tsai","year":"2022","unstructured":"Tsai CJ, McBride SM, Riaz N et al (2022) Evaluation of substantial reduction in elective radiotherapy dose and field in patients with human papillomavirus-associated oropharyngeal carcinoma treated with definitive chemoradiotherapy. JAMA Oncol 8(3):364. https:\/\/doi.org\/10.1001\/jamaoncol.2021.6416","journal-title":"JAMA Oncol"},{"key":"7710_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2020.104652","volume":"105","author":"EO Bigelow","year":"2020","unstructured":"Bigelow EO, Seiwert TY, Fakhry C (2020) Deintensification of treatment for human papillomavirus-related oropharyngeal cancer: current state and future directions. Oral Oncol 105:104652. https:\/\/doi.org\/10.1016\/j.oraloncology.2020.104652","journal-title":"Oral Oncol"},{"issue":"5","key":"7710_CR18","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1002\/hed.27019","volume":"44","author":"F Petrelli","year":"2022","unstructured":"Petrelli F, Luciani A, Ghidini A et al (2022) Treatment de-escalation for HPV+ oropharyngeal cancer: a systematic review and meta-analysis. Head Neck 44(5):1255\u20131266","journal-title":"Head Neck"},{"issue":"1","key":"7710_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003019","volume":"17","author":"JF Tierney","year":"2020","unstructured":"Tierney JF, Fisher DJ, Burdett S, Stewart LA, Parmar M (2020) Comparison of aggregate and individual participant data approaches to meta-analysis of randomised trials: an observational study. PLoS Med 17(1):e1003019. https:\/\/doi.org\/10.1371\/journal.pmed.1003019","journal-title":"PLoS Med"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-022-07710-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-022-07710-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-022-07710-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T03:13:17Z","timestamp":1675653197000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-022-07710-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,20]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["7710"],"URL":"https:\/\/doi.org\/10.1007\/s00405-022-07710-2","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,20]]},"assertion":[{"value":"30 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"n\/a.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"n\/a.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}},{"value":"n\/a.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Permission to reproduce material from other sources"}},{"value":"n\/a.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registration"}}]}}